JP7051059B2 - Menstruation-related information notification system for low-dose pill users - Google Patents

Description

The present invention relates to a system for notifying menstrual-related information (eg, menstrual days, side effect information) to those taking oral contraceptives OC (Oral Controltives), so-called low-dose pills.

Low-dose pills are taken as one of the contraceptive measures. In addition, low-dose pills are not only contraceptive means, but also reduce dysmenorrhea (menstrual pain), improve menstrual irregularities, prevent and improve endometriosis, reduce premenstrual symptoms (PMS), and acne / hirsutism. It is also used for improvement of menstrual symptoms and prevention of dysmenorrhea.
To get contraceptive benefits with low-dose pills, low-dose pills should be taken at approximately fixed times each day. Therefore, in addition to medication instruction by doctors and pharmacists, descriptive ideas for assigning days to so-called PTP packaging sheets containing low-dose pills, and changing the color of low-dose pills and the pattern of PCT packaging sheets are colorful. Ingenuity has been applied.

If the menstrual period (menstrual period) can be managed accurately, the quality of life (QOL) can be improved. Taking low-dose pills daily according to usage is convenient for managing menstrual days, as the menstrual days are naturally determined. However, even with low-dose pills to control menstrual days, it can be difficult and annoying to manage and recognize menstrual days on your own in your daily life.

By the way, as mentioned above, low-dose pills cannot be fully effective unless they are taken at almost a fixed time every day.
For medicines in general, things like pill cases or medicine storage boxes that support daily medication are known (for example, Patent Document 1). In addition, a system or a terminal device that supports medication via a network is also known (for example, Patent Documents 2 and 3).

Japanese Unexamined Patent Publication No. 2012-217802 Japanese Unexamined Patent Publication No. 2009-125386 Japanese Unexamined Patent Publication No. 2016-91419

If you take low-dose pills daily as you would, your period will be determined by itself, so you can manage and recognize your period yourself. On the other hand, even if you do not manage your period by yourself, it is convenient if you can recognize your period when it is close to your period, for example, by having your smartphone notify you.
The present invention provides novel menstrual-related information that allows low-dose pill users to be notified by a third party of, for example, near the menstrual day (menstrual day) without having to manage the menstrual day by themselves. The main issue is to provide a notification system.

As a result of diligent studies, the present inventors have conceived a menstruation-related information notification system that can solve the above-mentioned problems, and have completed the present invention.

Examples of the present invention include the following.

[1] A device capable of telecommunications (information communication device) and an information device on the administration side (administrator information) installed in a pill case that can store a PTP packaging sheet containing a low-dose pill. The devices) and the information device on the administration side (administrator information device) and the information device terminal on the low-dose pill user side (taker terminal) are connected via a telecommunication line, and the following A system for notifying low-dose pill users of menstruation-related information, which comprises the steps 1 to 3 of the above:
1. 1. The information and communication device of the pill case that sensed that the low-dose pill was about to be taken or would have been taken due to the actions of the low-dose pill user, or the side of the person taking the low-dose pill. The user terminal in the process of transmitting the dose execution information to the administrator information device together with the user ID,
2. 2. The administrator information device that has received the dosing execution information accumulates the electronic data information, and monitors the dosing progress of the ID taker based on the accumulated information, and 3. Based on the monitoring of the progress of administration, the administrator information device is a step of transmitting menstruation-related information to the user terminal or information communication device of the ID user.
[2] The menstruation-related information notification system for low-dose pill users according to the above [1], which further comprises one or more steps of any one of the following a to d:
a. The administrator information device that determines from the monitoring of the course of administration that the low-dose pill has not been taken within the range of 1 to 3 days, or that the low-dose pill has not been taken at the time of taking the ID user, is the same. The process of transmitting information notifying that to the user terminal or information communication device of the ID user,
b. The administrator information device is a process of transmitting information notifying that the time is around the time of taking the ID user to the user terminal or information communication device of the person taking the ID.
c. The administrator information device is information for accelerating or delaying the menstruation of the ID user, and transmits the start date or end date of taking the medium-dose pill to the user terminal or information communication device of the ID user. Steps, and d. The administrator information device is the process of transmitting information on the side effects that may occur due to taking low-dose pills to the user terminal or information communication device.
[3] Detects that a PTP packaging sheet containing a low-dose pill can be stored and that the low-dose pill is about to be taken or would have been taken due to the actions of the low-dose pill user. A PTP packaging sheet containing a low-dose pill, comprising a device capable of, and a device capable of transmitting information sensed by the device to an administrator information device via a telecommunications line. A pill case that can store.

According to the present invention, even if a person taking a low-dose pill does not manage or be aware of the menstrual day, he / she can lead a daily life while grasping the menstrual day (menstrual day) by a report from a third party. It can improve medication compliance for low-dose pill users.

It is a schematic diagram which showed one aspect of this invention. Circled numbers indicate the process order in the present invention.

The menstruation-related information notification system for low-dose pill users (hereinafter referred to as "the system of the present invention") according to the present invention is installed in a pill case that can store a PTP packaging sheet containing a low-dose pill. Between devices capable of electrical information communication (information and communication devices) and information devices on the dose administrator side (administrator information device), and information devices on the dose administrator side (administrator information device) and low-dose pills. The information device terminal (taker terminal) on the user side is connected to each other via a telecommunications line, and is characterized by including the following steps 1 to 3.
1. 1. The information and communication device contained in the pill case, or taking the low-dose pill, which senses that the low-dose pill is about to be taken or would have been taken due to the actions of the low-dose pill taker. The user terminal on the user side sends the dose execution information to the administrator information device together with the user ID.
2. 2. The administrator information device that has received the dosing execution information accumulates the electronic data information, and monitors the dosing progress of the ID taker based on the accumulated information, and 3. Based on the monitoring of the progress of administration, the administrator information device is a step of transmitting menstruation-related information to the user terminal or information communication device of the ID user.

The information communication device and the administrator information device, and the administrator information device and the user terminal are usually connected wirelessly or by wire via a telecommunication line such as the Internet. Similarly, the information communication device and the user terminal may be connected wirelessly or by wire via a telecommunication line such as the Internet.

Here, the "telecommunications line" refers to a communication network capable of electrically transmitting information such as video, voice, and characters, and specific examples thereof include the Internet and (mobile) telephone lines. However, it is usually the Internet.

A "low-dose pill" (oral contraceptive OC) is a drug (tablet) in which the amount of two types of female hormone drugs, such as a luteinizing hormone drug and an estrogen drug, is reduced to the minimum amount at which a contraceptive effect can be obtained. The female hormone drug reduces follicle-stimulating hormone (FSH) and luteinizing hormone (LH) secreted from the brain, inhibits follicle growth, and prevents ovulation. In addition, the luteal hormone drug thickens the endometrium, making it difficult for sperms to implant in the uterus, and thickens the mucous membrane of the cervical canal at the entrance of the uterus, making it difficult for sperms to enter the uterus.

Low-dose pill luteinizing hormones (progesterone-based) include, for example, desogestrel, levonorgestrel, norethisterone, and drospirenone. Examples of low-dose pill egg yolk hormone drugs (estrogen-based) include ethinyl estradiol and estradiol.

In Japan, low-dose pills are, for example, Trickular® Tablets, Maveron® Tablets, Labelfille® Tablets, Synphase® Tablets, Anju® Tablets, Faboir (Registered Trademark). It is sold under trade names such as Trademark) Tablets, Yards® Combination Tablets, Lunabell® Combination Tablets, and Friwell® Combination Tablets. Low-dose pills include those containing 21 tablets in a PTP packaging sheet (1 cycle to 1 course) and those containing 28 tablets. The 21-tablet type contains an active ingredient (female hormone drug), and after taking the drug for 3 weeks, the drug is withdrawn for 1 week, and this is considered as 1 course. The 28-tablet type is a placebo drug that contains the active ingredient (female hormone drug) in 21 tablets and no active ingredient in the remaining 7 tablets, and after taking the drug for 3 weeks. I took a placebo for a week, and this is one course. Also, for the 21 tablets containing the active ingredient, the hormone amount is all constant, with 6 tablets taken first, 5 tablets taken next, and 10 tablets taken last. Is gradually increasing. For low-dose pills such as Trickular® tablets and Labelfille® tablets, there are 21-tablet type and 28-tablet type in PTP packaging sheets, but the amount of hormone is gradually increased. .. In the case of Trickular (registered trademark) tablets and Labelfille (registered trademark) tablets, the content is 0.050 mg for the progesterone drug, 0.030 mg for the egg yolk hormone drug, and then for the first 6 tablets to be taken. For the 5 tablets to be taken, the progesterone drug is 0.075 mg and the egg yolk hormone drug is 0.040 mg, and for the last 10 tablets to be taken, the progesterone drug is 0.125 mg and the egg yolk hormone drug is 0.030 mg. .. On the other hand, in low-dose pills such as Maveron (registered trademark), there are 21-tablet type and 28-tablet type in PTP packaging sheets, similar to Trickular (registered trademark) tablets, but the amount of hormone is constant. .. In the case of Maveron (registered trademark), the content thereof is 0.15 mg for the luteinizing hormone drug and 0.03 mg for the egg yolk hormone drug.

Taking low-dose pills, depending on the type of low-dose pill, should, as a rule, begin on the first or second day of menstruation or on the Sunday when menstruation begins. Then, take one tablet daily, in the order of the tablets, at the time decided by yourself. Since the tablets are taken daily in the prescribed order, which of the PTP packaging sheets containing low-dose pills is usually taken from the first tablet to the 21st to 28th tablets. Is there or is basically shown. If you do not adhere to it, you may not be fully effective as a low-dose pill. In that respect, it differs from general drugs.

Hereinafter, the system of the present invention will be described in detail with reference to the drawings as necessary.
1 About Step 1 Step 1 is an information communication device included in the pill case that senses that the low-dose pill is about to be taken or would have been taken due to the actions of the low-dose pill taker ( In the drawing, reference numeral 2) or the user terminal on the side of the user who took the low-dose pill (reference numeral 4 in the drawing) transmits the administration execution information together with the user ID to the administrator information device (reference numeral B in the drawing). Is.

The pill case according to the present invention (reference numeral A in the drawing) can store a PTP packaging sheet (reference numeral 1 in the drawing) containing a low-dose pill, and is low-dose due to the actions of a low-dose pill user. It is not particularly limited as long as it has a device capable of detecting that the pill is about to be taken or that it will have been taken (hereinafter, also referred to as “dose sensing device”; reference numeral 3 in the drawing). The dose sensing device 3 is connected to the information communication device 2. Examples of the form of the pill case include a wallet type, a business card case type, a pouch type, and a box type.
The information communication device 2 is not particularly limited as long as it can transmit electronic data information via a telecommunication line. This is usually installed in a pill case containing a PTP packaging sheet 1 containing a low dose pill.

The fact that the low-dose pill is about to be taken or would have been taken due to the actions of the low-dose pill taker is, for example, after the taker takes the PTP packaging sheet 1 out of the pill case and takes it. When the PTP packaging sheet 1 is returned to the pill case, the dosing sensing device 3 senses that the weight of the PTP packaging sheet 1 is reduced, and the low-dose pill is released from the PTP packaging sheet 1. This can be done by sensing traces of extruding (eg, tearing of the discharge surface of the PTP packaging sheet 1 or disappearance of one low-dose pill). Alternatively, for example, when the pill case limits the number of times the PTP packaging sheet 1 is taken out per day, the dose sensing device 3 detects that the pill case has been opened. Can be done. The dose sensing device 3 can transmit the sensing information to the information communication device 2.

As described above, for example, when the weight loss of the PTP packaging sheet 1 or the trace indicating that the low-dose pill has been extruded from the PTP packaging sheet 1 is detected, the sensed information is the information communication included in the pill case. The information and communication device 2 transmitted to the device 2 and received the transmission considers that the user has taken the low-dose pill, and transmits the administration execution information together with the user ID to the administrator information device B. The user ID is for identifying the user, and if it is possible, the type of ID is not particularly limited. Generally, the ID is a character string consisting of numbers, alphabets (uppercase letters, lowercase letters), hyphens, etc., or electronic data corresponding thereto.
Further, the user who has taken the low-dose pill can also use the user terminal 4 to transmit the administration execution information to the administrator information device B. In this case, the user terminal 4 transmits the dose execution information together with the user ID to the administrator information device B.

The administrator information device B that receives the transmitted administration execution information and user ID (hereinafter, also referred to as “dose execution information, etc.”) can receive at least electronic data information, and stores and stores the information. However, the device is not particularly limited as long as it is a device capable of monitoring the administration progress of the ID user according to the next step. Examples of the administrator information device B include computers such as personal computers (PCs), supercomputers, and embedded computers, and mobile terminals such as smartphones, tablets, and mobile phones, which are terminal devices having a user interface function. It may be a host computer such as a server.

2 About step 2 Step 2 is a step in which the administrator information device B, which has received the dosing execution information and the like, accumulates the electronic data information and monitors the dosing progress of the ID user based on the accumulated information. .. In such monitoring, the administrator information device B mainly stores the dose execution information, etc., grasps the transmission date, etc. of the dose execution information, etc. from the user terminal 4, and calculates the transmission days, period, etc. It is done by.

Regarding the dose execution information and the like received by the administrator information device B, the transmission date and time and the user information and the like are usually grasped by the data processing means in the administrator information device B. The number of non-sending days, the period of taking the drug, the period of non-administration, etc. are calculated. All of these data are usually stored (stored) in a suitable storage medium. Examples of the data processing means include processors such as CPUs and MPUs. Suitable storage media include, for example, a magnetic recording device (hard disk, etc.), an optical disk (CD, DVD, Blu-ray (registered trademark), etc.), an optical magnetic recording medium, a semiconductor memory (flash memory, DRAM, SRAM, etc.). Can be mentioned.

As mentioned above, those who take low-dose pills for the first time should take the first tablet on the first or second day of menstruation, or on the first Sunday when menstruation begins, at a time determined by themselves (hereinafter referred to as "time of administration"). .) Take around. When the dose execution information and the user ID of the user are transmitted from the information communication device 2 or the user terminal 4 to the administrator information device B, the administrator information device B receives them and processes internal data. The means grasps that the user has taken the first tablet and the date and time, and stores these data in the storage medium. The dosing time can be stored and managed in the administrator information device B in advance by notification from the taking person, but it is also possible to store and manage the time when the first tablet is transmitted as the taking time.
For low-dose pills, the tablets taken from the first tablet to the 21st (final) to 28th (final) tablets on the PTP packaging sheet in which they are stored are basically. It is decided to. If you do not follow it, you may not be able to get the desired low-dose pill effect.

The next day, when the second tablet is taken and the dose execution information and the user ID of the user are similarly transmitted from the information communication device 2 or the user terminal 4 to the administrator information device B, the administrator information The device B grasps that the user has taken the second tablet by the data processing means and the date and time thereof, and stores it in the storage medium together with the administration execution information and the like. Similarly, every day, the dose execution information and the like of the user are stored in the storage medium of the administrator information device B. In this way, the dosing execution information and the like of the taking person are accumulated in the administrator information device B. At this time, the total number of transmission days and non-transmission days up to that point, the dosing period and the non-dosing period of the user are calculated by the data processing means, and these data are also accumulated in the same manner.

If the administrator information device B does not receive the dosing execution information, etc. within the range of 1 to 3 days, or if the dosing time of the ID user, for example, 1 hour has passed, the dosing execution information, etc. can be obtained. If the administrator information device B does not receive the information, the administrator information device B can also transmit the information notifying the fact to the user terminal 4 or the information communication device 2 of the ID user. Examples of the notification information include "The previous day's dose cannot be confirmed" and "Today's dose cannot be confirmed even after 1 hour has passed from the time of administration." Such notifications can inform you that you have forgotten to take low-dose pills and improve your compliance with low-dose pills.
If the low-dose pill is not taken for 3 days or more, the effect of the low-dose pill cannot be fully obtained (reset). Therefore, in order to obtain the effect, tablets (21 tablets) for the total number of days taken. Or you may have to start over with a new PTP packaging sheet containing (28 tablets).

Further, the administrator information device B can also transmit information notifying that the time is taken by the ID user to the user terminal 4 or the information communication device 2 of the ID user. Such notifications can help prevent forgetting to take the day and improve low-dose pill compliance.

3 About Step 3 Step 3 is a step in which the administrator information device B transmits menstruation-related information to the user terminal 4 or the information communication device 2 of the ID user based on the monitoring of the administration progress.
In the system of the present invention, the administrator information that normally receives the administration execution information of the low-dose pills from the first tablet to the 21st tablet, and stores and accumulates the above-mentioned data grasped and calculated from them. Based on these stored and accumulated data, the device B calculates the menstrual-related information of the ID user by the data processing means and notifies the user terminal 4 or the information communication device 2 of the ID user. Menstruation-related information may include, for example, the day when menstruation will begin. As the notification date, in addition to the day desired by the user, for example, the day when the administrator information device B receives the 21st tablet, and the day between the next day and about 3 days later can be mentioned. Further, the notification date may be a day (eg, the day before, the day before the previous day) before the day when the administrator information device B receives the 21st tablet, if necessary. The notification may be performed not only once but also a plurality of times, and the content of the notification may be different for each time. As a result, the user can easily grasp the day when menstruation begins without having to manage the menstrual day by himself / herself. If menstruation does not start even if the notification is given, the possibility of pregnancy can be suspected.

When the administrator information device B receives the administration information of all 21 tablets for 21 days, it is preferable that the administrator information device B notifies the user terminal 4 or the like that menstruation starts, but one day in 21 days. Alternatively, even if the dosing execution information for the 2nd day is not received, the administrator information device B can notify the taking person terminal 4 or the like of the ID taking person that menstruation starts. In that case, it is also possible to notify that there is a day when the patient did not take the medicine and that the day when menstruation starts may be different.
In the case of 21-tablet type low-dose pills, after taking the 21st tablet, there will be a 7-day washout period, during which the drug including placebo tablets will not be taken, but the time when the drug holiday ends (7 from the 21st tablet dosing date). A day later or around the day before), the administrator information device B may notify the user terminal 4 or the information communication device 2 of the ID user to that effect. This allows the recipient to know that the next course is about to begin, i.e., that the next new PTP packaging sheet low-dose pill must be taken, and can improve medication compliance.

Whether it is a 21-tablet low-dose pill or a 28-tablet low-dose pill, 28 days is one course, and steps 1 to 3 of the system of the present invention are usually repeated every 28 days. Although there are individual differences, as the number of cools increases, the menstrual start date of the ID user is almost specified, so that the administrator information device B can notify the user of highly accurate information. It will be like. In the case of the first course or the second course, the day when menstruation starts may not be sufficiently specified, so the administrator information device B notifies the user's terminal etc. to that effect. You may.

4 Other steps In the system of the present invention, for example, the following steps can be included.
c. The administrator information device B is information for accelerating or delaying the menstruation of the ID user, and sets the start date or end date of taking the medium-dose pill to the user terminal 4 or the information communication device 2 of the ID user. The process of sending to, or d. The administrator information device B is a step of transmitting information on side effects that may occur due to taking a low-dose pill to the user terminal 4 or the information communication device 2.
Step c relates to the step of notifying information for menstrual transfer with medium dose pills. Step d relates to a step of notifying side effect information due to taking a low dose pill.

4.1 Information notification for menstrual transfer with medium-dose pills Although there are individual differences, start taking medium-dose pills by the 5th day after the start of menstruation before the menstruation you want to accelerate, and start the menstruation you want to accelerate. If you continue taking the drug until 2 to 3 days before the desired date and stop taking it, menstruation will start 2 to 3 days later, so you can accelerate your period. On the other hand, if you start taking the medium-dose pill 5 to 7 days before your scheduled start of menstruation, continue taking it until the day you want to avoid menstruation (eg, travel or test days), and then stop taking it 2-3. Menstruation begins a day later, so you can delay your period.

In the system of the present invention, if a person taking a low-dose pill wants to accelerate menstruation by taking a medium-dose pill, the administrator information device B may, for example, start menstruation on the day when the menstruation notified by step 3 starts or actually starts. Information that you should start taking medium-dose pills on the day between the first day and the 5th day, and stop taking medium-dose pills on the day 2-3 days before the desired start date of menstruation that you want to accelerate. Information that should be done can be transmitted to the user terminal 4 or the information communication device 2 of the low-dose pill taker.

If a person taking a low-dose pill wants to slow down menstruation by taking a medium-dose pill, for example, the administrator information device B that has received the dosing execution information around the 17th to 19th tablets starts taking the medium-dose pill. If the administrator information device B knows in advance the information that it should be avoided and the day when you want to avoid menstruation, for example, the information that you should stop taking the medium-dose pill on that day, It can be transmitted to the user terminal 4 or the information communication device 2 of the low-dose pill user.
As a result of the above, low-dose pill users who desire menstrual transfer can know when to take the medium-dose pill by notification from a third party, and can improve the compliance of the medium-dose pill.

Medium-dose pills, like low-dose pills, contain luteinizing and estrogen drugs, but in larger amounts than low-dose pills. Medium dose pills are commercially available, for example, under trade names such as Planovar® and Sophia A®. Planovar®, a combination tablet of norgestrel and ethinyl estradiol, contains 0.5 mg of norgestrel (a progesterone) and 0.05 mg of ethinyl estradiol (an egg yolk hormone), more than low-dose pills.

4.2 Notification of side effect information Taking low-dose pills may cause side effects such as nausea, headache, swelling, breast pain, and abnormal bleeding. It is said that the side effects are especially likely to occur in the first few days of administration.

In the system of the present invention, the above-mentioned side effect information can be transmitted to the user terminal 4 or the like of the low-dose pill user to notify the user. For example, the user terminal 4 of the person taking the low-dose pill transmits information on the side effect caused to the person taking the low-dose pill to the administrator information device B, the administrator information device B stores the side effect information, and the administrator information device B Can be transmitted to the user terminal 4 or the like of another user. This makes it possible to reduce side effect information from taking low-dose pills to those taking low-dose pills and share them among those taking low-dose pills. Specifically, for example, a lot of side effect information that a low-dose pill called A tablet is likely to cause headache in the early stage of taking the low-dose pill is sent from the initial user of the low-dose pill to the administrator information device B, and the information is managed. When the person information device B accumulates, the information can be notified to the user terminal 4 of another initial user, and the user can alleviate the anxiety caused by taking the low-dose pill as much as possible.
As described above, the system of the present invention includes a step in which the administrator information device B, which has accumulated information on side effects that may occur due to taking a low-dose pill, transmits the information to the user terminal 4 or the information communication device 2. Can be done.

5 About the pill case for carrying out the system of the present invention The pill case (hereinafter referred to as "the pill case of the present invention") that can store the PTP packaging sheet containing the low-dose pill according to the present invention is a low-dose pill. A device that can store the stored PTP packaging sheet and can detect that the low-dose pill is about to be taken or would have been taken due to the actions of the low-dose pill taker. It is characterized by including a sensing device) and a device (information communication device) capable of transmitting information sensed by the device to an administrator information device via a telecommunications line.

The pill case of the present invention usually has a size, shape, and the like that can accommodate a PTP packaging sheet of a commercially available low-dose pill. It is preferable that the PTP packaging sheet has a size and a shape that can store one to several sheets so that it can be easily carried, but it is not limited thereto. Examples of the form of the pill case of the present invention include a wallet type, a business card case type, a pouch type, a box type, a smartphone case type, a compact (foundation case) type, and a pen case type.

As a dosing sensing device capable of detecting that a low-dose pill is about to be taken or would have been taken due to the actions of a low-dose pill taker, for example, the taker is the PTP. A weigh scale that can detect that the weight of the PTP packaging sheet is decreasing when the packaging sheet is taken out of the pill case, taken, and then returned to the pill case, or a low-dose pill. Examples include sensors capable of detecting traces of extruding from a PTP packaging sheet (eg, tearing of the drain surface of the PTP packaging sheet or disappearance of one low-dose pill). Alternatively, in the case of a pill case in which the removal of the PTP packaging sheet is limited to, for example, once a day, a sensor that can detect that the pill case has been opened or that the PTP packaging sheet has been taken out. And so on.

As a device (information communication device) capable of transmitting information detected by the dose sensing device to the administrator information device via a telecommunication line, for example, electronic data information can be transmitted via a telecommunication line. A device having a computer having various functions can be mentioned. The computer of the device has a built-in processor such as a CPU and an MPU.

The system of the present invention is useful for a person taking a low-dose pill to know the menstrual day (the day when menstruation begins) and to take the low-dose pill safely and securely. Therefore, the system of the present invention is also useful for market distribution of low-dose pills.

A pill case (pill case of the present invention)
B Administrator information device 1 Low-dose pill storage PTP packaging sheet 2 Information and communication device 3 Dosing sensing device 4 Taker terminal

Claims (3)

A device capable of telecommunications (information communication device) and an information device on the administration side (administrator information device) installed in a pill case that can store a PTP packaging sheet containing a low-dose pill. The information device on the administration side (administrator information device) and the information device terminal on the low-dose pill user side (administrator terminal) are connected via a telecommunication line, and the following 1- A system for notifying menstruation-related information to low-dose pill users, which comprises three means :
1. 1. At least one of the group consisting of a reduction in the weight of the PTP packaging sheet, tearing of the discharge surface of the PTP packaging sheet, disappearance of one low-dose pill, and opening of the pill case by the dosing sensing device provided in the pill case. By detecting one, the information and communication device of the pill case, or the low dose, which sensed that the low dose pill was about to be taken or would have been taken due to the actions of the low dose pill taker. The user terminal on the side of the user who took the pill is a means of transmitting the administration execution information together with the user ID to the administrator information device.
2. 2. The administrator information device that has received the dose execution information is a means for accumulating the dose execution information and monitoring the dose progress of the user specified by the user ID based on the transmission date and time of the accumulated information.
3. 3. Based on the dose execution information , the administrator information device sends the user 's menstruation start date specified by the dose execution information to the user 's user terminal or information communication device specified by the user ID . A means of sending information about. The menstruation-related information notification system for low-dose pill users according to claim 1, further comprising any one or more of the following means a to d:
a. The administrator information device receives the dosing execution information when the dosing execution information is not received within the range of 1 to 3 days, or from the taking person even after a predetermined period has passed from the taking time of the taking person. If not, a means of transmitting information notifying that fact to the user's terminal or information communication device,
b. The administrator information device is a means for transmitting information notifying that it is the taking time to the taking person's terminal or information communication device at the taking time decided by the taking person.
c. The administrator information device is information for accelerating or delaying the menstruation of the person taking the drug, and based on the information received from the person taking the drug on the day when he / she wants to avoid menstruation, the start date or the end date of taking the medium-dose pill. Means to transmit to the user's terminal or information communication device of the user, and d. An administrator information device is a means of transmitting information on possible side effects of taking low-dose pills to a user terminal or information communication device. In the means 3, as the administration execution information, the administration execution information of the low-dose pills from the first tablet to the 21st tablet is received, and the administration execution information is received.
The menstruation-related information notification to the low-dose pill user according to claim 1 or 2, wherein when the 21st tablet administration execution information is received, the information on the menstruation start date of the user is transmitted. system.

Images